Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 22 Uterine Cervical Dysplasia 15 Papillomavirus Infections 7 Precancerous Conditions 5 Neoplasms 4 Squamous Intraepithelial Lesions 2 Genital Diseases 2 Atypical Squamous Cells of the Cervix 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Sexually Transmitted Diseases, Viral 1 Sexually Transmitted Diseases 1 Papilloma 1 Neoplasms, Squamous Cell 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 HIV Infections 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Female Urogenital Diseases and Pregnancy Complications 1 Cervical Intraepithelial Neoplasia Grade 2/3 1 Cervical Intraepithelial Neoplasia Grade 1 (CIN 1) 1 Adenocarcinoma in Situ 1

Interventions

Doxorubicin 20 Vincristine 17 Zidovudine 13 Cyclophosphamide 12 Bleomycin 12 Etoposide 10 Rituximab 6 Prednisone 6 Interferon alpha-2 6 Cytarabine 6 Liposomes 5 Filgrastim 5 Dexamethasone 5 tecogalan 4 sargramostim 4 Specimen Handling 4 Methotrexate 4 Magnetic Resonance Spectroscopy 4 Leucovorin 4 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4 Fluorouracil 4 Biopsy 4 Peripheral Blood Stem Cell Transplantation 3 Paclitaxel 3 Nivolumab 3 interferon alfa-n1 2 fludarabine phosphate 2 fludarabine 2 cabozantinib 2 Whole-Body Irradiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HIV Infections × Colposcopy × Clear all

NCT05074264 2025-11-10

CAMPO-101

University of California, San Francisco

Phase NA Active not recruiting

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡